Manuel Ramos-Casals Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

1/2022	Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
12/2021	Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications.
1/2020	Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
1/2019	Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
1/2019	Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
1/2019	Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
1/2019	Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
10/2018	Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
1/2016	Off-label use of rituximab for systemic lupus erythematosus in Europe.
7/2015	Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manuel Ramos-Casals Research Topics

Disease

21	Infections 01/2022 - 08/2002
20	Vasculitis (Vasculitides) 01/2022 - 03/2004
19	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 03/2003
18	Neoplasms (Cancer) 01/2024 - 08/2003
16	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2006
12	Cryoglobulinemia 01/2022 - 08/2003
10	Sarcoidosis (Schaumann Disease) 11/2021 - 03/2004
6	Peripheral Nervous System Diseases (PNS Diseases) 03/2011 - 03/2004
5	Dry Eye Syndromes (Dry Eye Syndrome) 11/2023 - 03/2007
5	COVID-19 12/2022 - 01/2021
5	Cytopenia 01/2022 - 03/2003
5	Arthritis (Polyarthritis) 05/2021 - 03/2004
5	Virus Diseases (Viral Diseases) 04/2021 - 08/2006
5	Fatigue 01/2021 - 07/2010
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017 - 01/2004
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2010 - 04/2006
4	Lymphoma (Lymphomas) 01/2022 - 07/2008
4	Anemia 01/2022 - 02/2004
4	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2003
4	Uveitis 01/2021 - 03/2004
4	Lupus Nephritis 01/2016 - 06/2011
4	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 07/2015 - 04/2010
4	Leukopenia 01/2015 - 07/2008
4	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2011 - 07/2007
4	Rheumatoid Arthritis 10/2011 - 07/2005
4	Vascular Skin Diseases 02/2007 - 04/2002
3	Systemic Scleroderma (Systemic Sclerosis) 12/2021 - 02/2007
3	Fever (Fevers) 01/2021 - 12/2006
3	Hypertension (High Blood Pressure) 01/2019 - 09/2003
3	Chronic Hepatitis C 04/2017 - 03/2003
3	Lung Diseases (Lung Disease) 01/2015 - 03/2005
3	Liver Diseases (Liver Disease) 12/2013 - 08/2006
3	Renal Insufficiency (Renal Failure) 03/2012 - 11/2008
2	Sialadenitis 12/2022 - 03/2004
2	Granuloma 12/2022 - 05/2011
2	Autoimmune Hepatitis 12/2021 - 01/2010
2	Lymphopenia (Lymphocytopenia) 01/2021 - 05/2018
2	Inflammation (Inflammations) 01/2021 - 05/2015
2	Pain (Aches) 01/2019 - 09/2014
2	Immunoglobulin G4-Related Disease 06/2016 - 07/2015
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 02/2016 - 11/2008
2	Fibrosis (Cirrhosis) 05/2015 - 03/2003
2	Sjogren's Syndrome (Sjogren Syndrome) 09/2014 - 02/2013
2	Arthralgia (Joint Pain) 02/2013 - 07/2010
2	Disease Progression 01/2013 - 07/2003
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 07/2012 - 11/2008
2	Microscopic Polyangiitis 07/2012 - 04/2006
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2011 - 05/2011
2	Myositis (Idiopathic Inflammatory Myopathies) 11/2008 - 02/2004
2	Raynaud Disease (Raynaud's Disease) 07/2008 - 03/2004
2	Thyroiditis 07/2008 - 05/2006
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2005 - 08/2003

Drug/Important Bio-Agent (IBA)

18	AntibodiesIBA 12/2022 - 04/2002
17	CryoglobulinsIBA 01/2022 - 03/2003
14	AutoantibodiesIBA 01/2022 - 08/2002
14	Rituximab (Mabthera)FDA Link 01/2016 - 01/2004
12	Rheumatoid FactorIBA 05/2018 - 03/2004
10	GlucocorticoidsIBA 01/2022 - 07/2012
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011 - 07/2005
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2003
8	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2005
8	Antinuclear AntibodiesIBA 01/2019 - 04/2002
7	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 03/2003
7	Etanercept (Enbrel)FDA Link 02/2015 - 07/2007
6	Immune Checkpoint InhibitorsIBA 01/2024 - 05/2019
6	Infliximab (Remicade)FDA Link 11/2011 - 07/2007
5	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021 - 09/2003
5	Immunoglobulin G (IgG)IBA 04/2017 - 02/2004
4	Monoclonal AntibodiesIBA 01/2024 - 03/2011
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 02/2013
4	CytokinesIBA 05/2021 - 08/2002
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 03/2007
4	Immunoglobulins (Immunoglobulin)IBA 11/2013 - 03/2005
3	SS-A antibodiesIBA 12/2022 - 03/2004
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2018 - 02/2004
3	Immunoglobulin M (IgM)IBA 04/2017 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 02/2004
3	Adalimumab (Humira)FDA Link 07/2011 - 07/2007
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2021
2	Janus Kinase InhibitorsIBA 01/2022 - 05/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
2	Antimalarials (Antimalarial Agents)IBA 12/2021 - 11/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 11/2008
2	AutoantigensIBA 04/2021 - 05/2015
2	SteroidsIBA 01/2021 - 09/2015
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2017 - 01/2016
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2016 - 07/2005
2	Immunoglobulin E (IgE)IBA 07/2015 - 06/2011
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2012 - 02/2007
2	Pilocarpine (Ocusert)FDA LinkGeneric 07/2010 - 03/2007
2	cevimeline (Evoxac)FDA Link 07/2010 - 03/2007
2	Complement System Proteins (Complement)IBA 04/2010 - 02/2004
2	Interferon-alpha (Interferon Alfa)IBA 03/2005 - 03/2003

Therapy/Procedure

38	Therapeutics 01/2022 - 03/2003
8	Biological Therapy 12/2016 - 11/2008
7	Immunotherapy 12/2022 - 01/2018
3	Off-Label Use 01/2016 - 11/2008
2	Immunomodulation 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2019 - 12/2016
2	Aftercare (After-Treatment) 06/2016 - 03/2005